Yvonne Diaz: New hope for our small cell lung cancer community in the UK
Yvonne Diaz, EY Global Media Relations and Social Media Director posted on X about a recent article by
“New hope for our small cell lung cancer community in the UK as MHRA News Centre’s grants conditional authorisation for Amgen‘s IMDYLLTRA (tarlatamab) for extensive-stage SCLC.
Great to see options for ‘difficult to treat’ SCLC as Professor Alastair Greystoke says.”
“Amgen’s lung cancer treatment gets conditional approval”
Yvonne Diaz serves as EY Global Media Relations and Social Media Director, with a team of over 20 professionals across multiple locations. The team supports EY’s global business objectives, brand aspirations, and overall reputation through various media and social media channels.
Her background includes leadership roles in external communications and media relations within the financial and media industries.
More posts featuring Yvonne Diaz.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023